BGI-Shenzhen Completes Tender Offer for Complete Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – BGI-Shenzhen said today that it has completed its cash tender offer for Complete Genomics, setting the stage for the merger of the two firms to be finalized.

The offer, which has been delayed numerous times, expired at 11:59 EDT March 14. As of the expiration of the offer, the depositary for the offer indicated that 31.4 million shares, or 88 percent, of Complete's stock had been validly tendered and not withdrawn.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.